1. Home
  2. Pharma & Healthcare
  3. Global and United States Japanese Encephalitis Virus Vaccine Market Report & Forecast 2022-2028

Global and United States Japanese Encephalitis Virus Vaccine Market Report & Forecast 2022-2028

Publication Month: Mar 2022 | No. of Pages: 145 Published By: Reports Intellect
Single User License: US $ 3660
Corporate User License: US $ 7320

Summary:

Japanese Encephalitis vaccine info for parents, public, and healthcare professionals.

Market Analysis and Insights: Global and United States Japanese Encephalitis Virus Vaccine Market

This report focuses on global and United States Japanese Encephalitis Virus Vaccine market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Japanese Encephalitis Virus Vaccine market size is estimated to be worth US$ 220.9 million in 2022 and is forecast to a readjusted size of US$ 300.3 million by 2028 with a CAGR of 5.3% during the review period. Fully considering the economic change by this health crisis, by Type, Inactivated Vaccine accounting for % of the Japanese Encephalitis Virus Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Public was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Japanese Encephalitis Virus Vaccine market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.

Global Japanese Encephalitis Virus Vaccine Scope and Market Size

Japanese Encephalitis Virus Vaccine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Japanese Encephalitis Virus Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Japanese Encephalitis Virus Vaccine market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Japanese Encephalitis Virus Vaccine market is segmented into

Inactivated Vaccine

Live Attenuated Vaccine

Segment by Application, the Japanese Encephalitis Virus Vaccine market is segmented into

Public

Private

Regional and Country-level Analysis

By Region

North America

the United States

Canada

Europe

Germany

France

UK

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Landscape and Japanese Encephalitis Virus Vaccine Market Share Analysis

Japanese Encephalitis Virus Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Japanese Encephalitis Virus Vaccine business, the date to enter into the Japanese Encephalitis Virus Vaccine market, Japanese Encephalitis Virus Vaccine product introduction, recent developments, etc.

The major vendors covered:

Research Foundation for Microbial Diseases of Osaka University

Valneva Austria GmbH

Chengdu Institute

Liaoning Dacheng

Wuhan Institute

Table of Contents


1 Study Coverage

    1.1 Japanese Encephalitis Virus Vaccine Product Introduction

    1.2 Global Japanese Encephalitis Virus Vaccine Outlook 2017 VS 2022 VS 2028

        1.2.1 Global Japanese Encephalitis Virus Vaccine Sales in US$ Million for the Year 2017-2028

        1.2.2 Global Japanese Encephalitis Virus Vaccine Sales in Volume for the Year 2017-2028

    1.3 United States Japanese Encephalitis Virus Vaccine Outlook 2017 VS 2022 VS 2028

        1.3.1 United States Japanese Encephalitis Virus Vaccine Sales in US$ Million for the Year 2017-2028

        1.3.2 United States Japanese Encephalitis Virus Vaccine Sales in Volume for the Year 2017-2028

    1.4 Japanese Encephalitis Virus Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028

        1.4.1 The Market Share of United States Japanese Encephalitis Virus Vaccine in Global, 2017 VS 2022 VS 2028

        1.4.2 The Growth Rate of Japanese Encephalitis Virus Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028

    1.5 Japanese Encephalitis Virus Vaccine Market Dynamics

        1.5.1 Japanese Encephalitis Virus Vaccine Industry Trends

        1.5.2 Japanese Encephalitis Virus Vaccine Market Drivers

        1.5.3 Japanese Encephalitis Virus Vaccine Market Challenges

        1.5.4 Japanese Encephalitis Virus Vaccine Market Restraints

    1.6 Study Objectives

    1.7 Years Considered

2 Market by Type

    2.1 Japanese Encephalitis Virus Vaccine Market Segment by Type

        2.1.1 Inactivated Vaccine

        2.1.2 Live Attenuated Vaccine

    2.2 Global Japanese Encephalitis Virus Vaccine Market Size by Type

        2.2.1 Global Japanese Encephalitis Virus Vaccine Sales in Value, by Type (2017, 2022 & 2028)

        2.2.2 Global Japanese Encephalitis Virus Vaccine Sales in Volume, by Type (2017, 2022 & 2028)

        2.2.3 Global Japanese Encephalitis Virus Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    2.3 United States Japanese Encephalitis Virus Vaccine Market Size by Type

        2.3.1 United States Japanese Encephalitis Virus Vaccine Sales in Value, by Type (2017, 2022 & 2028)

        2.3.2 United States Japanese Encephalitis Virus Vaccine Sales in Volume, by Type (2017, 2022 & 2028)

        2.3.3 United States Japanese Encephalitis Virus Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)

3 Market by Application

    3.1 Japanese Encephalitis Virus Vaccine Market Segment by Application

        3.1.1 Public

        3.1.2 Private

    3.2 Global Japanese Encephalitis Virus Vaccine Market Size by Application

        3.2.1 Global Japanese Encephalitis Virus Vaccine Sales in Value, by Application (2017, 2022 & 2028)

        3.2.2 Global Japanese Encephalitis Virus Vaccine Sales in Volume, by Application (2017, 2022 & 2028)

        3.3.3 Global Japanese Encephalitis Virus Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    3.3 United States Japanese Encephalitis Virus Vaccine Market Size by Application

        3.3.1 United States Japanese Encephalitis Virus Vaccine Sales in Value, by Application (2017, 2022 & 2028)

        3.3.2 United States Japanese Encephalitis Virus Vaccine Sales in Volume, by Application (2017, 2022 & 2028)

        3.3.3 United States Japanese Encephalitis Virus Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)

4 Global Japanese Encephalitis Virus Vaccine Competitor Landscape by Company

    4.1 Global Japanese Encephalitis Virus Vaccine Market Size by Company

        4.1.1 Top Global Japanese Encephalitis Virus Vaccine Manufacturers Ranked by Revenue (2021)

        4.1.2 Global Japanese Encephalitis Virus Vaccine Revenue by Manufacturer (2017-2022)

        4.1.3 Global Japanese Encephalitis Virus Vaccine Sales by Manufacturer (2017-2022)

        4.1.4 Global Japanese Encephalitis Virus Vaccine Price by Manufacturer (2017-2022)

    4.2 Global Japanese Encephalitis Virus Vaccine Concentration Ratio (CR)

        4.2.1 Japanese Encephalitis Virus Vaccine Market Concentration Ratio (CR) (2017-2022)

        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Japanese Encephalitis Virus Vaccine in 2021

        4.2.3 Global Japanese Encephalitis Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

    4.3 Global Japanese Encephalitis Virus Vaccine Manufacturing Base Distribution, Product Type

        4.3.1 Global Japanese Encephalitis Virus Vaccine Manufacturers, Headquarters and Distribution of Producing Region

        4.3.2 Manufacturers Japanese Encephalitis Virus Vaccine Product Type

        4.3.3 Date of International Manufacturers Enter into Japanese Encephalitis Virus Vaccine Market

    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans

    4.5 United States Japanese Encephalitis Virus Vaccine Market Size by Company

        4.5.1 Top Japanese Encephalitis Virus Vaccine Players in United States, Ranked by Revenue (2021)

        4.5.2 United States Japanese Encephalitis Virus Vaccine Revenue by Players (2020, 2021 & 2022)

        4.5.3 United States Japanese Encephalitis Virus Vaccine Sales by Players (2020, 2021 & 2022)

5 Global Japanese Encephalitis Virus Vaccine Market Size by Region

    5.1 Global Japanese Encephalitis Virus Vaccine Market Size by Region: 2017 VS 2022 VS 2028

    5.2 Global Japanese Encephalitis Virus Vaccine Market Size in Volume by Region (2017-2028)

        5.2.1 Global Japanese Encephalitis Virus Vaccine Sales in Volume by Region: 2017-2022

        5.2.2 Global Japanese Encephalitis Virus Vaccine Sales in Volume Forecast by Region (2023-2028)

    5.3 Global Japanese Encephalitis Virus Vaccine Market Size in Value by Region (2017-2028)

        5.3.1 Global Japanese Encephalitis Virus Vaccine Sales in Value by Region: 2017-2022

        5.3.2 Global Japanese Encephalitis Virus Vaccine Sales in Value by Region: 2023-2028

6 Segment in Region Level & Country Level

    6.1 North America

        6.1.1 North America Japanese Encephalitis Virus Vaccine Market Size YoY Growth 2017-2028

        6.1.2 North America Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)

        6.1.3 the United States

        6.1.4 Canada

    6.2 Asia-Pacific

        6.2.1 Asia-Pacific Japanese Encephalitis Virus Vaccine Market Size YoY Growth 2017-2028

        6.2.2 Asia-Pacific Japanese Encephalitis Virus Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)

        6.2.3 China

        6.2.4 Japan

        6.2.5 South Korea

        6.2.6 India

        6.2.7 Australia

        6.2.8 China Taiwan

        6.2.9 Indonesia

        6.2.10 Thailand

        6.2.11 Malaysia

    6.3 Europe

        6.3.1 Europe Japanese Encephalitis Virus Vaccine Market Size YoY Growth 2017-2028

        6.3.2 Europe Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)

        6.3.3 Germany

        6.3.4 France

        6.3.5 UK

        6.3.6 Italy

        6.3.7 Russia

    6.4 Latin America

        6.4.1 Latin America Japanese Encephalitis Virus Vaccine Market Size YoY Growth 2017-2028

        6.4.2 Latin America Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)

        6.4.3 Mexico

        6.4.4 Brazil

        6.4.5 Argentina

    6.5 Middle East and Africa

        6.5.1 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size YoY Growth 2017-2028

        6.5.2 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)

        6.5.3 Turkey

        6.5.4 Saudi Arabia

        6.5.5 UAE

7 Company Profiles

    7.1 Research Foundation for Microbial Diseases of Osaka University

        7.1.1 Research Foundation for Microbial Diseases of Osaka University Corporation Information

        7.1.2 Research Foundation for Microbial Diseases of Osaka University Description and Business Overview

        7.1.3 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2017-2022)

        7.1.4 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Products Offered

        7.1.5 Research Foundation for Microbial Diseases of Osaka University Recent Development

    7.2 Valneva Austria GmbH

        7.2.1 Valneva Austria GmbH Corporation Information

        7.2.2 Valneva Austria GmbH Description and Business Overview

        7.2.3 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2017-2022)

        7.2.4 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Products Offered

        7.2.5 Valneva Austria GmbH Recent Development

    7.3 Chengdu Institute

        7.3.1 Chengdu Institute Corporation Information

        7.3.2 Chengdu Institute Description and Business Overview

        7.3.3 Chengdu Institute Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2017-2022)

        7.3.4 Chengdu Institute Japanese Encephalitis Virus Vaccine Products Offered

        7.3.5 Chengdu Institute Recent Development

    7.4 Liaoning Dacheng

        7.4.1 Liaoning Dacheng Corporation Information

        7.4.2 Liaoning Dacheng Description and Business Overview

        7.4.3 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2017-2022)

        7.4.4 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Products Offered

        7.4.5 Liaoning Dacheng Recent Development

    7.5 Wuhan Institute

        7.5.1 Wuhan Institute Corporation Information

        7.5.2 Wuhan Institute Description and Business Overview

        7.5.3 Wuhan Institute Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2017-2022)

        7.5.4 Wuhan Institute Japanese Encephalitis Virus Vaccine Products Offered

        7.5.5 Wuhan Institute Recent Development

8 Industry Chain and Sales Channels Analysis

    8.1 Japanese Encephalitis Virus Vaccine Industry Chain Analysis

    8.2 Japanese Encephalitis Virus Vaccine Key Raw Materials

        8.2.1 Key Raw Materials

        8.2.2 Japanese Encephalitis Virus Vaccine Distributors

    8.3 Japanese Encephalitis Virus Vaccine Production Mode & Process

    8.4 Japanese Encephalitis Virus Vaccine Sales and Marketing

        8.4.1 Japanese Encephalitis Virus Vaccine Sales Channels

        8.4.2 Japanese Encephalitis Virus Vaccine Distributors

    8.5 Japanese Encephalitis Virus Vaccine Customers

9 Research Findings and Conclusion

10 Appendix

    10.1 Research Methodology

        10.1.1 Methodology/Research Approach

        10.1.2 Data Source

    10.2 Author Details

    10.3 Disclaimer

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets